Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Mina Komuta

Clin Mol Hepatol. 2022;28(3):396-407. Published online January 14, 2022

DOI: https://doi.org/10.3350/cmh.2021.0287

View: 6524 Download: 360 Web of Science: 16 Crossref: 17

Jaejun Lee, Taeyun Kim, Hyun Yang, Si Hyun Bae

Clin Mol Hepatol. 2022;28(2):196-206. Published online January 13, 2022

DOI: https://doi.org/10.3350/cmh.2021.0371

View: 6108 Download: 213 Web of Science: 15 Crossref: 17

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Gavin E. Arteel

Clin Mol Hepatol. 2020;26(4):670-676. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0174

View: 6202 Download: 132 Web of Science: 12 Crossref: 11

Jihye Kim, Bumhee Yang, Namyoung Paik, Yon Ho Choe, Yong-Han Paik

Clin Mol Hepatol. 2017;23(3):260-264. Published online July 7, 2017

DOI: https://doi.org/10.3350/cmh.2016.0057

View: 8390 Download: 142 Web of Science: 9 Crossref: 8

Hae-Sook Shon, Hwa Young Choi, Jang Rak Kim, So Yeon Ryu, Youn-Jae Lee, Myeong Jin Lee, Hyun Ju Min, Jun Lee, Yeong Jun Song, Moran Ki

Clin Mol Hepatol. 2015;21(3):249-256. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.249

View: 9295 Download: 86 Web of Science: 13 Crossref: 12

Si Hyun Bae

Clin Mol Hepatol. 2008;14(3):309-317. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.309

View: 6777 Download: 97 Crossref: 10

Jae Kwon Jung , Jin Tae Jung , Chang Hyeong Lee , Eun Young Kim , Joong Goo Kwon , Byung Seok Kim

Clin Mol Hepatol. 2007;13(3):409-413. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.409

View: 4889 Download: 74 Crossref: 6

1 |

Viewed By 5240	MAFLD: How is it different from NAFLD?
Viewed By 4998	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4905	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4673	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4651	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 219	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 162	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 136	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 120	MAFLD: How is it different from NAFLD?
Cited By 98	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search